Ahn-Gook Pharmaceutical Co., Ltd. (KOSDAQ:001540)
11,500
+560 (5.12%)
At close: May 29, 2026
Ahn-Gook Pharmaceutical Revenue
Ahn-Gook Pharmaceutical had revenue of 98.93B KRW in the quarter ending March 31, 2026, with 30.59% growth. This brings the company's revenue in the last twelve months to 330.05B, up 17.40% year-over-year. In the year 2025, Ahn-Gook Pharmaceutical had annual revenue of 306.87B with 13.19% growth.
Revenue (ttm)
330.05B
Revenue Growth
+17.40%
P/S Ratio
0.39
Revenue / Employee
844.12M
Employees
391
Market Cap
130.13B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 306.87B | 35.76B | 13.19% |
| Dec 31, 2024 | 271.12B | 37.44B | 16.02% |
| Dec 31, 2023 | 233.68B | 28.29B | 13.77% |
| Dec 31, 2022 | 205.39B | 41.85B | 25.59% |
| Dec 31, 2021 | 163.53B | 20.17B | 14.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cosmax Nbt | 308.56B |
| H.PIO | 258.19B |
| DongKoo Bio & Pharma | 242.08B |
| Kyung Dong Pharmaceutical | 198.27B |
| GC WellBeing | 179.05B |
| HYUNDAI BIOLAND | 135.04B |
| OPTUS Pharmaceutical | 91.62B |
| KOREA PHARMA | 91.42B |